China Generic Injectables Market
5 regulatory pivots redefining aseptic manufacturing in 2026 As 2026 begins, the National Medical Products Administration has implemented a series of stringent quality consistency evaluations specifically targeting parenteral formulations. These new mandates require all local production facilities to align with high-level international sterile processing standards, fundamentally shifting the...
0 Комментарии 0 Поделились 12 Просмотры 0 предпросмотр
Lifesone https://lifesone.com